5-hydroxydecanoate has been researched along with Insulin Resistance in 1 studies
5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katakam, PV | 1 |
| Jordan, JE | 1 |
| Snipes, JA | 1 |
| Tulbert, CD | 1 |
| Miller, AW | 1 |
| Busija, DW | 1 |
1 other study available for 5-hydroxydecanoate and Insulin Resistance
| Article | Year |
|---|---|
Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance.
Topics: Animals; Decanoic Acids; Diazoxide; Hydroxy Acids; Immunoblotting; In Vitro Techniques; Insulin Resi | 2007 |